Search

Quanterix Corp

Fermé

SecteurSoins de santé

2.91 6.99

Résumé

Variation du prix de l'action

24h

Actuel

Min

2.67

Max

2.95

Chiffres clés

By Trading Economics

Revenu

-31M

-49M

Ventes

-3.5M

33M

BPA

-0.45

Marge bénéficiaire

-148.708

Employés

450

EBITDA

-38M

-49M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+10.29% upside

Dividendes

By Acuity

Prochains Résultats

9 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.2M

118M

Ouverture précédente

-4.08

Clôture précédente

2.91

Sentiment de l'Actualité

By Acuity

50%

50%

129 / 339 Classement par Healthcare

Quanterix Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 sept. 2026, 20:01 UTC

Quanterix Corp shares are higher during Tuesday's session, maintaining positive momentum despite a broader market decline tied to the NY Empire State Manufacturing Index.

14 sept. 2026, 20:03 UTC

News

Quanterix Corp appointed Dr. Yuri Fesko as Chief Medical Officer, yet shares are trading lower amid ongoing performance weakness.

11 sept. 2026, 19:26 UTC

Quanterix Corp shares are higher amid market response to steady inflation data. Earlier, the stock pulled back from a session high before regaining momentum.

10 sept. 2026, 20:07 UTC

Quanterix Corp shares are lower today, pressured by broader market conditions following the European Central Bank's interest rate hike.

9 sept. 2026, 20:07 UTC

Quanterix Corp shares are lower today, reaching a session low amid ongoing weakness and trading near the lower end of their one-month range.

8 sept. 2026, 20:07 UTC

Quanterix Corp shares are higher today, reflecting broader market dynamics amid speculation over a potential Federal Reserve interest rate hike.

4 sept. 2026, 20:08 UTC

Quanterix Corp shares are higher today, continuing a strong upward trend since Thursday's close, despite broader market pressures from a strong jobs report.

3 sept. 2026, 20:07 UTC

Quanterix Corp shares are lower today, continuing a decline since Wednesday. The stock is near the lower end of its one-month range.

2 sept. 2026, 19:46 UTC

Quanterix Corp shares are higher today, though still below their 20-day moving average. Broader market conditions are affected by rising U.S. Treasury yields.

1 sept. 2026, 20:01 UTC

Quanterix Corp shares are lower today, continuing a decline since Monday. Broader market concerns include rising oil prices and inflation expectations.

31 août 2026, 19:16 UTC

Quanterix Corp shares are lower amid market anxiety following hawkish remarks from Federal Reserve Chair Kevin Warsh on potential interest rate hikes.

28 août 2026, 23:41 UTC

Quanterix Corp shares are lower in after-market trading, following a decline earlier in the session amid rising U.S. Treasury yields and falling tech stocks.

24 août 2026, 20:02 UTC

Quanterix Corp shares are lower today, continuing a decline that began Friday. The stock is near the lower end of its one-month range.

22 août 2026, 00:02 UTC

Quanterix Corp shares are lower in after-market trading, continuing a decline since Friday's close, with no specific news identified for the movement.

20 août 2026, 20:06 UTC

Quanterix Corp shares are higher today amid increased market activity. The stock's movement aligns with broader trends, including rising U.S. Treasury yields and crude oil prices.

19 août 2026, 22:31 UTC

Quanterix Corp shares are higher in after-market trading, reflecting a broader equity rebound after the Treasury's announcement of increased buyback operations for longer-term debt.

18 août 2026, 23:06 UTC

Quanterix Corp. shares are roughly flat in after-market hours. The stock remains near the lower end of its one-month range.

17 août 2026, 20:01 UTC

News

Quanterix Corp shares are higher after Director William P. Donnelly's insider purchase of 72,245 shares at $2.93, despite a price target cut by Canaccord Genuity.

14 août 2026, 23:01 UTC

Quanterix Corp shares are higher in after-market trading, despite no specific news. This follows mixed market sentiment after a decline in U.S. retail sales.

13 août 2026, 20:02 UTC

Quanterix Corp shares are lower today amid a broader decline in the Life Sciences Tools & Services sub-sector, continuing a downward trend since Wednesday.

12 août 2026, 23:01 UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

11 août 2026, 22:51 UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

10 août 2026, 19:51 UTC

Event
Social Media
News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

7 août 2026, 19:16 UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

5 août 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

3 août 2026, 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

31 juil. 2026, 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

30 juil. 2026, 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

29 juil. 2026, 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

28 juil. 2026, 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

Comparaison

Variation de prix

Quanterix Corp prévision

Objectif de Prix

By TipRanks

10.29% hausse

Prévisions sur 12 Mois

Moyen 3 USD  10.29%

Haut 3 USD

Bas 3 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Sentiment

By Acuity

129 / 339Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat